1. Home
  2. BCDA vs PNBK Comparison

BCDA vs PNBK Comparison

Compare BCDA & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • PNBK
  • Stock Information
  • Founded
  • BCDA N/A
  • PNBK 1999
  • Country
  • BCDA United States
  • PNBK United States
  • Employees
  • BCDA N/A
  • PNBK N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • PNBK Major Banks
  • Sector
  • BCDA Health Care
  • PNBK Finance
  • Exchange
  • BCDA Nasdaq
  • PNBK Nasdaq
  • Market Cap
  • BCDA 7.9M
  • PNBK 6.6M
  • IPO Year
  • BCDA N/A
  • PNBK N/A
  • Fundamental
  • Price
  • BCDA $2.63
  • PNBK $1.85
  • Analyst Decision
  • BCDA Strong Buy
  • PNBK
  • Analyst Count
  • BCDA 1
  • PNBK 0
  • Target Price
  • BCDA $25.00
  • PNBK N/A
  • AVG Volume (30 Days)
  • BCDA 55.0K
  • PNBK 2.8M
  • Earning Date
  • BCDA 03-26-2025
  • PNBK 03-31-2025
  • Dividend Yield
  • BCDA N/A
  • PNBK N/A
  • EPS Growth
  • BCDA N/A
  • PNBK N/A
  • EPS
  • BCDA N/A
  • PNBK N/A
  • Revenue
  • BCDA $71,000.00
  • PNBK $27,300,000.00
  • Revenue This Year
  • BCDA N/A
  • PNBK N/A
  • Revenue Next Year
  • BCDA N/A
  • PNBK N/A
  • P/E Ratio
  • BCDA N/A
  • PNBK N/A
  • Revenue Growth
  • BCDA N/A
  • PNBK 3.61
  • 52 Week Low
  • BCDA $1.63
  • PNBK $1.33
  • 52 Week High
  • BCDA $8.85
  • PNBK $4.07
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 61.81
  • PNBK 51.97
  • Support Level
  • BCDA $2.27
  • PNBK $1.37
  • Resistance Level
  • BCDA $2.78
  • PNBK $2.47
  • Average True Range (ATR)
  • BCDA 0.27
  • PNBK 0.24
  • MACD
  • BCDA 0.02
  • PNBK 0.07
  • Stochastic Oscillator
  • BCDA 77.61
  • PNBK 45.61

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: